Skip to Main content Skip to Navigation
New interface
Journal articles

Apoptotic marker expression in the absence of cell death in staurosporine-treated Leishmania donovani

Abstract : The protozoan parasite Leishmania donovani undergoes several developmental transitions in its insect and vertebrate hosts that are induced by environmental changes. The roles of protein kinases in these adaptive differentiation steps and their potential as targets for antiparasitic intervention are only poorly characterized. Here, we used the generic protein kinase inhibitor staurosporine to gain insight into how interference with phosphotransferase activities affects the viability, growth, and motility of L. donovani promastigotes in vitro. Unlike the nonkinase drugs miltefosine and amphotericin B, staurosporine strongly reduced parasite biosynthetic activity and had a cytostatic rather than a cytotoxic effect. Despite the induction of a number of classical apoptotic markers, including caspase-like activity and surface binding of annexin V, we determined that, on the basis of cellular integrity, staurosporine did not cause cell death but caused cell cycle arrest and abrogated parasite motility. In contrast, targeted inhibition of the parasite casein kinase 1 (CK1) protein family by use of the CK1-specific inhibitor D4476 resulted in cell death. Thus, pleiotropic inhibition of L. donovani protein kinases and possibly other ATP-binding proteins by staurosporine dissociates apoptotic marker expression from cell death, which underscores the relevance of specific rather than broad kinase inhibitors for antiparasitic drug development.
Document type :
Journal articles
Complete list of metadata
Contributor : Marie Martin Connect in order to contact the contributor
Submitted on : Thursday, January 12, 2017 - 4:30:07 PM
Last modification on : Thursday, April 7, 2022 - 10:10:32 AM

Links full text




Aude L. Foucher, Najma Rachidi, Sarah Gharbi, Thierry Blisnick, Philippe Bastin, et al.. Apoptotic marker expression in the absence of cell death in staurosporine-treated Leishmania donovani. Antimicrobial Agents and Chemotherapy, 2013, 57 (3), pp.1252-1261. ⟨10.1128/AAC.01983-12⟩. ⟨pasteur-01433417⟩



Record views